Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Elevate ENT Partners Acquires San Antonio Head & Neck Surgical Associates
Elevate ENT Partners, a leading management support of ear, nose and throat (ENT) practices nationwide, announced on August 29 that it has acquired San Antonio Head & Neck Surgical Associates. San Antonio Head & Neck Surgical Associates offers treatment for medical and surgical disorders in the field of otolaryngology and head and neck surgery. According to its website, the practice has nine providers on staff. With more than 80 otolaryngology centers and 127 physicians, Elevate ENT Partners invests in private ENT and allergy practices across the United States and provides scalable infrastructure to help practices reach the next level in terms of financial management,... Read More »
Montecito Medical Acquires Chapel Hill, NC MOB
Montecito Medical Real Estate announced on August 28 its acquisition of an 11,515-square-foot medical building in Chapel Hill, North Carolina for an undisclosed price. The two-story MOB is fully occupied and tenanted to the UNC Physicians Network, part of UNC Health, which uses the property as an internal medicine clinic. UNC Health is one of the nation’s leading academic healthcare systems, with more than 33,000 employees providing care to patients in all of North Carolina’s 100 counties through its 11 hospitals and hundreds of clinical practices. Montecito Medical specializes in healthcare-related real estate acquisitions and funding. Since 2006, it has completed transactions... Read More »
FFL Partners Completes Growth Investment in Johnson County Clin-Trials
FFL Partners announced that it has completed a growth investment in Johnson County Clin-Trials (JCCT). According to data captured in the LevinPro HC database, this transaction represents the 20th clinical trials acquisition of 2023. Financial terms of the private transaction were not disclosed. JCCT is a clinical research site platform serving pharmaceutical and biotechnology companies and contract research organizations. Headquartered in Lenexa, Kansas, JCCT specializes in Phase I – IV clinical trials, encompassing both healthy volunteers and special populations. Since its inception in 2005, the company has concluded approximately 300 clinical trials, engaging more than 15,000... Read More »
New Story Acquires Virginia Assets of The Center for Autism & Related Disorder
New Story, a provider of special and alternative education and therapeutic services, announced its acquisition of the Virginia assets of the Center for Autism & Related Disorder (CARD) for an undisclosed amount. The Virginia assets include three school campuses and nine applied behavior analysis therapy clinics. CARD is one of the world’s largest and most experienced autism treatment providers and the third largest non-governmental organization in the United States contributing to autism research. Founded in 1997, New Story offers integrated academic and therapeutic programming to children and young adults with autism spectrum disorder, mental illness and emotional and... Read More »
Gruppo San Donato Acquires American Heart of Poland
Gruppo San Donato announced on August 25 its acquisition of American Heart of Poland, a health clinic with various locations across Poland. GKSD partnered with Gruppo San Donato for this transaction. American Heart of Poland manages more than 20 medical centers specializing in cardiology, cardio-surgery and vascular surgery. Gruppo San Donato is Italy’s largest private healthcare group with 56 medical sites. It has more than 5,500 beds. According to Masroor Haq, Head of Strategic Investments at investment manager GSKD, the transaction values American Heart of Poland at more than $539 million (€500 million). Mr. Haq also said that, following the completion of the... Read More »
RQM+ Acquires Germany-Based CRO Kottmann
RQM+ announced on August 28 its acquisition of CRO Kottmann for an undisclosed price. According to data captured in the LevinPro HC database, this transaction marks the 25th contract research organization (CRO) acquisition of 2023. CRO Kottmann is an international CRO based in Germany. The company conducts clinical studies with medical devices, in vitro diagnostics and pharmaceuticals. In addition to full service, CRO Kottmann also offers individual services such as the creation of databases, statistical evaluations and clinical monitoring for studies. RQM+ provides regulatory and quality solutions that accelerate the success of medical device companies. The company also... Read More »
Danaher Corporation Acquires Abcam plc for $5.7 Billion
Danaher Corporation announced on August 28 that it has entered into a definitive agreement to acquire Abcam plc. According to data captured in the LevinPro HC database, this acquisition represents the 94th Laboratories, MRI and Dialysis transaction of 2023. Danaher will acquire all the currently outstanding shares of Abcam at a price of $24.00 per share in cash. In total, this acquisition is valued at approximately $5.7 billion, which factors in assumed debts and deducts acquired cash. Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its products include primary and secondary antibodies, proteins, peptides, lysates,... Read More »
Q2:23 Thematic Earnings Roundup
This earnings season has provided us with insights into how various publicly traded healthcare companies are navigating the current landscape. Let’s delve into the trends and outcomes that defined the second quarter of 2023. The Home Health & Hospice Market: The Erosion of Medicare Fee-For-Service The Home Health & Hospice (HH&H) market has been volatile of late, with companies like Amedisys Inc. (NASDAQ: AMED) reporting a significant shortfall in earnings and a decline in revenue compared to the same period last year. Amedisys reported a financial loss in the second quarter of $80.3 million, after reporting a profit in the same 2022 period. A significant portion of this... Read More »
SANUWAVE Health Merges with SPAC SEP Acquisition Corp.
SANUWAVE Health Inc. has entered into a definitive merger agreement with SEP Acquisition Corp. Upon completion of the proposed transaction, the combined company is expected to operate under the SANUWAVE name and trade on the NASDAQ Capital Market under the symbol “SNWV”. SANUWAVE Health is commercial stage medical device company. It has two FDA approved products and its lead product, UltraMIST®, has nationwide schedule 1 reimbursement from CMS. According to its FY 2022 financial report, SANUWAVE had FY 2022 revenues of $16.7 million. SEP Acquisition Corp. is a Houston-based special purpose acquisition company (SPAC) affiliated with Sweat Equity Partners and Mercury Life... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
